Compound sulfamonomethoxine sodium micro-capsule preparation and preparation method thereof
A technology of sodium methotrexate and compound sulfonamide, which is applied in the field of preparation of animal medicines, can solve the problems of poor sterilization and parasite elimination, low penetrating power, and damage to the kidneys, so as to improve penetrating power, prevent Effects of controlling toxoplasmosis and reducing damage
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0025] A compound sulfamethoxine sodium microcapsule preparation, the raw materials for making it include 8% sulfamethoxine sodium and 1% trimethoprim by mass, and the quality of the auxiliary agent is One-third of the total mass of sulfamethoxine sodium and trimethoprim is 3%, and the balance is anhydrous glucose, which is 88%.
[0026] Wherein, the auxiliary agent consists of 1 part of soluble starch, 3 parts of petroleum ether, 1 part of acetaminophen, 1 part of polyvinylpyrrolidone, 1 part of escin, 3 parts of kanamycin monosulfate, 1 part Morinda citrifolia, 1 part otilonium bromide, 1 part vernimulin, 1 part probenecid sodium, 3 parts Brucea javanica, 2 parts forsythia, 3 parts purslane, 1 part aurantium and 1 part Psoralea composition.
Embodiment 2
[0028] A compound sulfamethoxine sodium microcapsule preparation, the raw materials for making it include sulfamethoxine sodium with a mass proportion of 10% and trimethoprim with a mass proportion of 2%, and the quality of the auxiliary agent is One-third of the total mass of sulfamethoxine sodium and trimethoprim is 4%, and the balance is anhydrous glucose, which is 84%.
[0029] Wherein, the auxiliary agent consists of 2 parts of soluble starch, 4 parts of petroleum ether, 2 parts of acetaminophen, 3 parts of polyvinylpyrrolidone, 2 parts of escin, 4 parts of kanamycin monosulfate, 2 parts of Morinda citrifolia, 2 parts of otilonium bromide, 3 parts of vernimulin, 3 parts of probenecid sodium, 4 parts of Brucea javanica, 3 parts of forsythia, 4 parts of purslane, 2 parts of aurantium and 2 parts Psoralea composition.
Embodiment 3
[0031] A compound sulfamethoxine sodium microcapsule preparation, the raw materials for making it include sulfamethoxine sodium with a mass proportion of 12% and trimethoprim with a mass proportion of 3%, and the quality of the auxiliary agent is One-third of the total mass of sulfamethoxine sodium and trimethoprim is 5%, and the balance is anhydrous glucose, which is 80%.
[0032] Wherein, the auxiliary agent consists of 3 parts of soluble starch, 5 parts of petroleum ether, 4 parts of acetaminophen, 4 parts of polyvinylpyrrolidone, 3 parts of escin, 5 parts of kanamycin monosulfate, 3 parts of Morinda officinalis, 3 parts of otilonium bromide, 5 parts of vernimulin, 4 parts of probenecid sodium, 5 parts of Brucea javanica, 4 parts of forsythia, 5 parts of purslane, 4 parts of aurantium and 3 parts of Psoralea composition.
[0033] combine figure 1 Shown, above-mentioned each embodiment all adopts following method to prepare:
[0034] A preparation method of compound sulfa...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com